Av Timofey Sovershaev
Postdoktor ved TREC
Direct oral anticoagulants (DOACs) are a new class of drugs that prevent excess blood clotting. They are widely used due to a number of advantages over the previous generation of drugs (Vitamin K antagonists – Warfarin / Marevan), namely – more controlled effects, no need to do regular blood test to adjust the dose and fewer complications. This study talks about the comparative safety of three of those drugs.